| Literature DB >> 35496779 |
Michele Crestani1, Tania Dini1, Nils C Gauthier1, Pascale Monzo1.
Abstract
Glioblastoma (GBM) cells invade the brain by following linear structures like blood vessel walls and white matter tracts by using specific motility modes. In this protocol, we describe two micropatterning techniques allowing recapitulation of these linear tracks in vitro: micro-contact printing and deep UV photolithography. We also detail how to maintain, transfect, and prepare human glioma propagating cells (hGPCs) for migration assays on linear tracks, followed by image acquisition and analysis, to measure key parameters of their motility. For complete details on the use and execution of this protocol, please refer to Monzo et al. (2016) and Monzo et al. (2021a).Entities:
Keywords: Biophysics; Biotechnology and bioengineering; Cancer; Cell Biology; Cell culture; Cell-based Assays; Microscopy
Mesh:
Year: 2022 PMID: 35496779 PMCID: PMC9043773 DOI: 10.1016/j.xpro.2022.101331
Source DB: PubMed Journal: STAR Protoc ISSN: 2666-1667
Figure 1Microcontact printing
(A) Preparation of PDMS (soft lithography). (a) elastomer base and cross-linking agent are mixed on a weighing board at 10:1 ratio. (b) PDMS is degassed under vacuum for 30 min. (c) PDMS is poured on the silicon wafer. (d) PDMS is degassed under vacuum for 30 min. (e) PDMS is cured for 2 h at 70°C. (f) PDMS is unmolded from the silicon wafer with a scalpel.
(B) Details of the various steps involved in microcontact printing. (a) PDMS is unmolded from the silicon wafer. (b) Stamps are cut in 1 cm2 squares and plasma-cleaned for 3 min. (c) Stamps are coated with laminin for 30 min. (d) stamp is blown with an air-gun to remove the excess of laminin. (e) Stamp is leant and removed from the substrate to perform microcontact printing.
(C) Main steps of microcontact printing: (a) The mixture of elastomer base and cross-linking agent (PDMS 10:1, previously degased) is poured on the silicon wafer (which has been silanized). (b) The PDMS on the silicon wafer is kept in a vacuum desiccator to remove all bubbles. (c) After curing, the PDMS is unmolded and cut into small stamps. The inset shows the gridded micropattern used in (Monzo et al., 2021a). (d) Stamps are plasma cleaned. (e) After incubation with laminin, the stamps are gently dried with an air-gun. (f) PDMS stamps are gently pressed onto the surface of the imaging dish to print laminin micropatterns (see inset). Scale bars are 100 μm.
Figure 2Deep-UV photolithography
(A) Principles of deep-UV lithography. PEGylated coverslips are placed on the chrome mask, bubbles are removed and the PLL-g-PEG is burned through the micropatterns drawn on the photomask, by deep UV, for 10 min. The coverslips are then mounted either on an imaging chamber or on a 35-mm dish with a hole, and coated with laminin at 37°C for 1 h.
(B) Main steps of deep-UV lithography: (a) acid washed and air-dried coverslips are placed in a coverslip holder for plasma cleaning. (b) plasma cleaned coverslips are coated with PEG-g-PLL. (c) PEGylated coverslips are placed onto a drop of milliQ water covering the micropatterns on the chrome mask. (d) The chrome mask is placed in the deep-UV machine coverslips facing down. (e) The coverslips are lifted from the chrome mask using milliQ water. (f) Micropatterned coverslips are mounted in magnetic imaging chambers.
Figure 3hGPC maintenance and transfection
(A) hGPC tumor-spheres as seen under the microscope (10× objective) after 5 days in culture.
(B) hGPCs after trituration (no spheres are present).
(C) hGPCs as a confluent monolayer grown on a laminin-coated dish.
(D) Neon pipette and Neon tip.
(E) Neon Electroporator setup.
(F and G) hGPCS transfected with GFP control vector 24 h after electroporation (GFP channel and phase contrast). Scale bars are 100 μm.
Figure 4hGPC imaging and manual tracking
(A and B) Setup used for time-lapse acquisition.
(C and D) Manual tracking plugin in ImageJ/Fiji and tracks. Bars are 100 μm.
(E) Maximum intensity projection: the images of each slice of the timelapse are overlaid on top of each other with ImageJ: Image>Stack> Z-project>MAX intensity.
(F) Resulting maximum intensity projection of the temporal stack of hGPCs migrating on the gridded micropattern over 7 h movie. Bar is 100 μm.
Figure 5From manual tracks to mean speed and persistence calculation
(A–F) visual instructions for mean speed, persistence and plot at origin representation. Error bars are S.D.
| REAGENT or RESOURCE | SOURCE | IDENTIFIER |
|---|---|---|
| 3-(trimethoxysilyl)-propyl methacrylate | Merck | Cat#M6514-25ML |
| Albumin from Bovine Serum (BSA), Alexa FluorTM 647 conjugate | Thermo Fisher Scientific | Cat#A34785 |
| B-27™ Supplement | Thermo Fisher Scientific | Cat#17504044 |
| Bovine serum albumin (BSA) | VWR | Cat#1000-70-500G |
| DMEM/F-12, GlutaMAX™ Supplement | Thermo Fisher Scientific | Cat#31331093 |
| Heparin sodium salt from porcine intestinal mucosa | Sigma-Aldrich | Cat#H3149-10KU |
| HEPES | Euroclone | Cat#ECM0180L |
| Hexamethyldisilazane | Sigma-Aldrich | Cat#440191 |
| Laminin Mouse Protein, Natural | Thermo Fisher Scientific | Cat#23017015 |
| Nitric Acid | Merck | Cat#84378-1L |
| Non-essential amino acid | Biowest | Cat#X-0557 |
| Penicillin/streptomycin | Euroclone | Cat#ECB3001 |
| PLL-PEG (PLL(20)-g[3.5]- PEG(2) | SuSoS | Cat#PLL(20)-g[3.5]- PEG(2) |
| Pluronic® F-127 | Sigma-Aldrich | Cat#P2443-250G |
| QIAfilter Plasmid Maxi Kit | QIAGEN | Cat#19743 |
| Recombinant Human EGF | PeproTech | Cat#AF-100-15 |
| Recombinant Human FGF-basic (154 a.a.) | PeproTech | Cat#100-18B |
| Sylgard 184 silicone elastomer kit | Dow Corning | Cat#1064291 |
| Sodium pyruvate | Biowest | Cat#L0642 |
| Tris ultrapure | Euroclone | Cat#EMR045001 |
| Trypsin-EDTA 1× in PBS | Euroclone | Cat#ECB3052D |
| Programs for speed and persistence measurements | ( | |
| NNI-21 | Carol Tang, National Neuroscience Institute (NNI) | N/A |
| NNI-24 | Carol Tang, National Neuroscience Institute (NNI) | N/A |
| NNI-11 | Carol Tang, National Neuroscience Institute (NNI) | N/A |
| ImageJ | ( | |
| Graph Pad Prism 9.0 | GraphPad | |
| Leica Application Suite (LAS) | Leica Microsystems | LAS |
| Microsoft Excel | Microsoft | N/A |
| Chrome mask | PHOTOMASK PORTAL | |
| Engraved silicon wafer | Mechanobiology Institute | MBI#395 |
| Fluorescence lamp | Leica Microsystems | Kubler codix |
| 1× Neon™ Transfection System 100 μL kit | Thermo Fisher Scientific | Cat#MPK10096 |
| Neon Transfection System | Thermo Fisher Scientific | Cat#MPK5000 |
| Glass bottom dishes, 35 mm | Mattek | Cat#P35G-1.5-20-C |
| Greiner dishes, petri dish, 35 × 10 mm, triple vented | Merck | Cat#P5112-740EA |
| Greiner dishes petri dish, 60 × 15 mm, vented (6 vents) | Merck | Cat#P5237-600EA |
| Microscope air pump | Okolab | OKO-AP |
| Microscope CO2 unit | Okolab | DGTCO2BX |
| Microscope heating unit | Okolab | H201-T |
| Microscope stage controller | Okolab | MW tango |
| TIRF microscope | Leica Microsystems | Leica AM TIRF MC |
| Plasma Cleaner | Harrick Plasma | PDC-32G-2 (230V) |
| Porcelain coverglass rack | Thomas scientific | N/A |
| Precision cover glasses thickness No. 1.5H (tol. ± 5 μm) for high performance microscopes, 24 mm Ø | Marienfeld | Cat#117640 |
| UVO cleaner | Jelight Company Inc. | 342-220 |
| Reagent | Final concentration | Total quantity |
|---|---|---|
| DMEM/F-12-glutamax (1×) | 1× | 500 mL |
| Sodium pyruvate (100 mM) | 1 mM | 5 mL |
| Non-essential amino acid (100×) | 1× | 5 mL |
| Penicillin/streptomycin (100×) | 1× | 5 mL |
| Reagent | Final concentration | Total quantity |
|---|---|---|
| DMEM/F-12-glutamax (1×) | n/a | 500 mL |
| Sodium pyruvate (100 mM) | 1 mM | 5 mL |
| Non-essential amino acid (100×) | 1× | 5 mL |
| Penicillin/streptomycin (100×) | 1× | 5 mL |
| BSA (Powder) | 5% | 25 g |
| 50× grow factor mix | Final concentration | Total quantity |
|---|---|---|
| B27 supplement (50×) | 50× | 2 mL |
| EGF (100 μg/mL) | 1 μg/mL | 20 μL |
| FGF (100 μg/mL) | 1 μg/mL | 20 μL |
| Heparin (5 mg/mL) | 250 μg/mL | 100 μL |